MX2016010431A - Composiciones para la prevencion y/o el tratamiento de patologias relacionadas con alfa-glucosidasa. - Google Patents
Composiciones para la prevencion y/o el tratamiento de patologias relacionadas con alfa-glucosidasa.Info
- Publication number
- MX2016010431A MX2016010431A MX2016010431A MX2016010431A MX2016010431A MX 2016010431 A MX2016010431 A MX 2016010431A MX 2016010431 A MX2016010431 A MX 2016010431A MX 2016010431 A MX2016010431 A MX 2016010431A MX 2016010431 A MX2016010431 A MX 2016010431A
- Authority
- MX
- Mexico
- Prior art keywords
- glucosidase
- alpha
- preventing
- conditions associated
- pathological conditions
- Prior art date
Links
- 102100024295 Maltase-glucoamylase Human genes 0.000 title abstract 3
- 108010028144 alpha-Glucosidases Proteins 0.000 title abstract 3
- 230000001575 pathological effect Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000004474 valine Substances 0.000 abstract 2
- 239000000413 hydrolysate Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La invención se refiere a una composición que comprende al menos un péptido XAP, en el cual X representa un conjunto vacío o una valina, para su utilización en la prevención y/o el tratamiento de patologías relacionadas con la alfa-glucosidasa. La invención se refiere también a la utilización de un hidrolizado de al menos una proteína, conteniendo dicha proteína, o estando constituida por, al menos 0,05% a <5% o al menos 5% de motivos XAP, en el cual X representa un conjunto vacío o una valina, para su utilización en la prevención y/o el tratamiento de patologías relacionadas con la alfa-glucosidasa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1451280A FR3017536B1 (fr) | 2014-02-18 | 2014-02-18 | Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase |
PCT/FR2015/050397 WO2015124867A1 (fr) | 2014-02-18 | 2015-02-18 | Compositions pour la prévention et/ou le traitement de pathologies liées a l'alpha-glucosidase |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2016010431A true MX2016010431A (es) | 2016-10-17 |
MX365952B MX365952B (es) | 2019-06-19 |
Family
ID=50549145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016010431A MX365952B (es) | 2014-02-18 | 2015-02-18 | Composiciones para la prevención y/o el tratamiento de patologías relacionadas con alfa-glucosidasa. |
Country Status (13)
Country | Link |
---|---|
US (1) | US10500245B2 (es) |
EP (1) | EP3107556B1 (es) |
JP (3) | JP6892265B2 (es) |
KR (1) | KR20160113736A (es) |
AU (1) | AU2015220649B2 (es) |
BR (1) | BR112016019002A2 (es) |
CA (1) | CA2944413C (es) |
DK (1) | DK3107556T3 (es) |
ES (1) | ES2732316T3 (es) |
FR (1) | FR3017536B1 (es) |
MX (1) | MX365952B (es) |
NZ (1) | NZ723300A (es) |
WO (1) | WO2015124867A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3017536B1 (fr) * | 2014-02-18 | 2017-05-26 | Univ La Rochelle | Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase |
CN114716524B (zh) | 2022-04-15 | 2023-05-23 | 中国农业大学 | 抑制α-淀粉酶和α-葡萄糖苷酶的熟小米醇溶蛋白肽 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6023087B2 (ja) * | 1982-09-04 | 1985-06-05 | 工業技術院長 | アンジオテンシン転換酵素阻害剤 |
CA2128044C (en) | 1993-08-05 | 2007-02-20 | Klaus-Dieter Bremer | Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor |
ES2239799T3 (es) * | 1997-02-05 | 2005-10-01 | F. Hoffmann-La Roche Ag | Uso de tetrahidrolipstatina en el tratamiento de la diabetes tipo ii. |
JP2002501889A (ja) * | 1998-02-02 | 2002-01-22 | トラスティーズ オブ タフツ カレッジ | グルコース代謝を調節する方法、およびそれに関連する試薬 |
JP2003024012A (ja) | 2001-07-18 | 2003-01-28 | National Institute Of Advanced Industrial & Technology | アンジオテンシンi変換酵素阻害剤及び血圧降下性機能食品 |
US20040229934A1 (en) * | 2002-10-21 | 2004-11-18 | Salim Yusuf | Method of reducing type 2 diabetes in high risk patients |
KR101174299B1 (ko) * | 2003-08-01 | 2012-08-16 | 칼피스가부시키가이샤 | 카세인 가수분해물, 그 제조법 및 그 용도 |
FR2861991B1 (fr) | 2003-11-07 | 2008-01-18 | Centre Nat Rech Scient | Utilisation d'inhibiteurs de glucosidase pour une therapie de la mucoviscidose |
US8637463B2 (en) * | 2003-12-01 | 2014-01-28 | Meiji Dairies Corporation | Peptide inhibiting angiotensin converting enzyme |
JP2008505653A (ja) * | 2004-07-12 | 2008-02-28 | ディーエスエム アイピー アセッツ ビー.ブイ. | 血圧降下タンパク質加水分解物 |
JP2006063074A (ja) * | 2004-07-29 | 2006-03-09 | Sankyo Co Ltd | 糖尿病治療薬を含有する医薬組成物 |
EP1786435A1 (en) * | 2004-08-10 | 2007-05-23 | Medicure International Inc. | Combination therapies employing vitamin b6 related compounds and ace inhibitors and uses thereof for the treatment of diabetic disorders |
US8273710B2 (en) * | 2004-12-23 | 2012-09-25 | Campina Nederland Holding B.V. | Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use |
EP1879465A1 (en) * | 2005-02-09 | 2008-01-23 | Unilever N.V. | Composition comprising peptide |
US7638488B2 (en) | 2005-03-08 | 2009-12-29 | Intermune, Inc. | Use of alpha-glucosidase inhibitors to treat alphavirus infections |
US20080274987A1 (en) * | 2006-06-07 | 2008-11-06 | Hej Research Institute | Novel alpha glucosidase activator, pulicarside 1 |
WO2008058888A1 (en) * | 2006-11-15 | 2008-05-22 | Unilever N.V. | Edible emulsions with polyphenols |
WO2012085266A2 (en) | 2010-12-23 | 2012-06-28 | Dialpha | Composition comprising cinnamon extract |
JP5887630B2 (ja) * | 2011-08-11 | 2016-03-16 | 岡山県 | ジペプチジルペプチダーゼ−iv阻害剤の製造方法 |
FR3017536B1 (fr) * | 2014-02-18 | 2017-05-26 | Univ La Rochelle | Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase |
-
2014
- 2014-02-18 FR FR1451280A patent/FR3017536B1/fr active Active
-
2015
- 2015-02-18 EP EP15709276.8A patent/EP3107556B1/fr active Active
- 2015-02-18 DK DK15709276.8T patent/DK3107556T3/da active
- 2015-02-18 MX MX2016010431A patent/MX365952B/es active IP Right Grant
- 2015-02-18 WO PCT/FR2015/050397 patent/WO2015124867A1/fr active Application Filing
- 2015-02-18 JP JP2016553415A patent/JP6892265B2/ja active Active
- 2015-02-18 KR KR1020167025715A patent/KR20160113736A/ko not_active IP Right Cessation
- 2015-02-18 US US15/119,032 patent/US10500245B2/en active Active
- 2015-02-18 BR BR112016019002A patent/BR112016019002A2/pt active Search and Examination
- 2015-02-18 ES ES15709276T patent/ES2732316T3/es active Active
- 2015-02-18 CA CA2944413A patent/CA2944413C/fr active Active
- 2015-02-18 NZ NZ723300A patent/NZ723300A/en unknown
- 2015-02-18 AU AU2015220649A patent/AU2015220649B2/en active Active
-
2019
- 2019-07-05 JP JP2019126262A patent/JP2019189647A/ja active Pending
-
2021
- 2021-07-01 JP JP2021110194A patent/JP2021165290A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20160113736A (ko) | 2016-09-30 |
BR112016019002A2 (pt) | 2017-10-10 |
CA2944413A1 (fr) | 2015-08-27 |
ES2732316T3 (es) | 2019-11-21 |
CA2944413C (fr) | 2023-05-23 |
JP2017511800A (ja) | 2017-04-27 |
JP6892265B2 (ja) | 2021-06-23 |
DK3107556T3 (da) | 2019-07-22 |
FR3017536B1 (fr) | 2017-05-26 |
EP3107556A1 (fr) | 2016-12-28 |
JP2019189647A (ja) | 2019-10-31 |
US20180104303A1 (en) | 2018-04-19 |
EP3107556B1 (fr) | 2019-04-10 |
AU2015220649B2 (en) | 2020-08-13 |
JP2021165290A (ja) | 2021-10-14 |
WO2015124867A1 (fr) | 2015-08-27 |
AU2015220649A1 (en) | 2016-08-11 |
FR3017536A1 (fr) | 2015-08-21 |
MX365952B (es) | 2019-06-19 |
NZ723300A (en) | 2022-12-23 |
US10500245B2 (en) | 2019-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019502279A1 (en) | Cleaning compositions and uses thereof | |
MX2018004683A (es) | Composicion detergente que comprende variantes de amilasa y proteasa. | |
MX2019003623A (es) | Composiciones y metodos para el tratamiento de afecciones oftalmicas. | |
MX2018005829A (es) | Composiciones para tratar el cabello. | |
MX2018000147A (es) | Moleculas de anticuerpo que se unen al grupo de diferenciacion 45 (cd45). | |
MX2018000351A (es) | Composición para el cuidado de telas que comprende poliolésteres insaturados metatesizados. | |
AU366476S (en) | Bottle | |
NZ730865A (en) | Peptides having anti-inflammatory properties | |
MX2018000470A (es) | Moleculas de anticuerpo que se unen al grupo de diferenciacion 22 (cd22). | |
PH12015501983A1 (en) | Peptides and compositions for treatment of joint damage | |
WO2015143046A3 (en) | Methods and compositions for regulation of zinc finger protein expression | |
MX2017001290A (es) | Composicion para el tratamiento de telas que comprende una nanoemulsion de polimero de aminosiloxano. | |
NZ727281A (en) | Stereochemically enriched compositions for delivery of nucleic acids | |
MX369041B (es) | Proteinas quimericas tipo fosfatasa alcalina. | |
SG10201808835QA (en) | Anti-siglec-8 antibodies and methods of use thereof | |
MX2018000590A (es) | Moleculas de anticuerpo que se unen a agrupacion de diferenciacion 79 (cd79). | |
PH12018500659A1 (en) | Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof | |
PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
SG10201808278TA (en) | Polishing composition and polishing method | |
BR112016023519A2 (pt) | inibidor de sinalização de wnt/ß-catenina, composição farmacêutica e método de tratamento e/ou prevenção de uma patologia definida por malformação vascular | |
MX2016016613A (es) | Composicion en forma de particulas compactadas y su uso. | |
MX365952B (es) | Composiciones para la prevención y/o el tratamiento de patologías relacionadas con alfa-glucosidasa. | |
MX2018007468A (es) | Composiciones de colageno 7 y metodos para usar las mismas. | |
PH12016501658A1 (en) | Sialylated glycoprotein compositions and uses thereof | |
MX2019009293A (es) | Compuestos, composiciones y usos de los mismos para la mejoria de trastornos oseos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |